(Q33931132)

30 July 2017

1 reference

title

High-dose chemotherapy and autologous stem cell transplantation for breast cancer. (English)

1 reference

30 July 2017

Baynes RD

1

1 reference

30 July 2017

Dansey RD

2

1 reference

30 July 2017

Klein JL

3

1 reference

30 July 2017

Karanes C

4

1 reference

30 July 2017

Cassells L

5

1 reference

30 July 2017

Abella E

6

1 reference

30 July 2017

Wei WZ

7

1 reference

30 July 2017

Galy A

8

1 reference

30 July 2017

Du W

9

1 reference

30 July 2017

Wood G

10

1 reference

30 July 2017

Peters WP

11

1 reference

30 July 2017

1 January 2000

1 reference

30 July 2017

1 reference

30 July 2017

18

1 reference

30 July 2017

5

1 reference

30 July 2017

440-455

1 reference

30 July 2017

Cancer statistics, 1998.

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Variation in approval by insurance companies of coverage for autologous bone marrow transplantation for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Remission induction and continuation therapy in children with their first relapse of acute lymphoid leukemia. A Pediatric Oncology Group study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

The place of third-generation regimens in the treatment of adult aggressive non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Long-Term Outcome of Patients with Relapsed and Refractory Germ Cell Tumors Treated with High-Dose Chemotherapy and Autologous Bone Marrow Rescue

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

A review of the management of germ cell tumors: evolution of a curative treatment program

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Ovarian carcinoma. A decade of progress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Mechanisms to improve chemotherapy effectiveness

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Adjuvant systemic therapy: state of the art, 1989.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

New concepts in the treatment of breast cancer using high-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose carboplatin, cyclophosphamide, and BCNU with autologous bone marrow support: excessive hepatic toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Bone-marrow transplantation (first of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Marrow Transplantation for Acute Nonlymphoblastic Leukemia in First Remission

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

The importance of dose intensity in chemotherapy of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Dose-response in the treatment of breast cancer: a critical review

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

A randomized trial of two dose levels of cyclophosphamide, methotrexate, and fluorouracil chemotherapy for patients with metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose combination alkylating agents with autologous bone marrow support: a Phase 1 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose combination alkylating agent chemotherapy with autologous bone marrow support for metastatic breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose chemotherapy with reinfusion of purged autologous bone marrow following dose-intense induction as initial therapy for metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose chemotherapy with autologous bone marrow transplantation for the treatment of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose consolidation therapy with autologous stem-cell rescue in stage IV breast cancer: follow-up report

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose doxorubicin, etoposide, and cyclophosphamide with stem cell reinfusion in patients with metastatic or high-risk primary breast cancer. City of Hope Bone Marrow Oncology Team

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose cisplatin, etoposide, and cyclophosphamide with autologous stem cell reinfusion in patients with responsive metastatic or high-risk primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose cyclophosphamide, carboplatin, and etoposide with autologous stem cell rescue in patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Phase II study of intensive chemotherapy with autologous bone marrow transplantation in patients in complete remission of disseminated breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

High-dose chemotherapy with hematopoietic rescue as primary treatment for metastatic breast cancer: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Hematopoietic progenitor cell transplantation in breast cancer: current status and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Impact of selection process on response rate and long-term survival of potential high-dose chemotherapy candidates treated with standard-dose doxorubicin-containing chemotherapy in patients with metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Minimal toxicity and mortality in high-risk breast cancer patients receiving high-dose cyclophosphamide, thiotepa, and carboplatin plus autologous marrow/stem-cell transplantation and comprehensive supportive care.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Patient selection in high-dose chemotherapy trials: relevance in high-risk breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Phase I trial of interferon gamma to potentiate cyclosporine-induced graft-versus-host disease in women undergoing autologous bone marrow transplantation for breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Autologous bone marrow purging by in situ IL-2 activation of endogenous killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Quality of life following bone marrow transplantation for breast cancer: a comparative study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Psychologic and neuropsychologic impact of autologous bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Myelodysplastic syndrome as a late complication following autologous bone marrow transplantation for non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

Efficacy and cost-effectiveness of autologous bone marrow transplantation in metastatic breast cancer. Estimates using decision analysis while awaiting clinical trial results

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F07357900009032816

10.3109/07357900009032816

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference